Cited by 484Influenza Virus Research StudiesVaccine Coverage and HesitancyRespiratory viral infections research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Nichol, Kristin L., Wuorenma, J., von Sternberg, T.·1998·Archives of Internal Medicine

Open this paper in CoChat — free account

Abstract

BACKGROUND: Vaccination rates for healthy senior citizens are lower than those for senior citizens with underlying medical conditions such as chronic heart or lung disease. Uncertainty about the benefits of influenza vaccination for healthy senior citizens may contribute to lower rates of utilization in this group. OBJECTIVE: To clarify the benefits of influenza vaccination among low-risk senior citizens while concurrently assessing the benefits for intermediate- and high-risk senior citizens. METHODS: All elderly members of a large health maintenance organization were included in each of 6 consecutive study cohorts. Subjects were grouped according to risk status: high risk (having heart or lung disease), intermediate risk (having diabetes, renal disease, stroke and/or dementia, or rheumatologic disease), and low risk. Outcomes were compared between vaccinated and unvaccinated subjects after controlling for baseline demographic and health characteristics. RESULTS: There were more than 20000 subjects in each of the 6 cohorts who provided 147551 person-periods of observation. The pooled vaccination rate was 60%. There were 101 619 person-periods of observation for low-risk subjects, 15 482 for intermediate-risk, and 30 450 for high-risk subjects. Vaccination over the 6 seasons was associated with an overall reduction of 39% for pneumonia hospitalizations (P<.001), a 32% decrease in hospitalizations for all respiratory conditions (P<.001), and a 27% decrease in hospitalizations for congestive heart failure (P<.001). Immunization was also associated with a 50% reduction in all-cause mortality (P<.001). Within the risk subgroups, vaccine effectiveness was 29%, 32%, and 49% for high-, intermediate-, and low-risk senior citizens for reducing hospitalizations for pneumonia and influenza (for high and low risk, P< or =.002; for intermediate risk, P = .11). Effectiveness was 19%, 39%, and 33% (for each, P< or =.008), respectively, for reducing hospitalizations for all respiratory conditions and 49%, 64%, and 55% for reducing deaths from all causes (for each, P<.001). Vaccination was also associated with direct medical care cost savings of $73 per individual vaccinated for all subjects combined (P = .002). Estimates of cost savings within each risk group suggest that vaccination would be cost saving for each subgroup (range of cost savings of $171 per individual vaccinated for high risk to $7 for low risk), although within the subgroups these findings did not reach statistical significance (for each, P> or =.05). CONCLUSIONS: This study confirms that healthy senior citizens as well as senior citizens with underlying medical conditions are at risk for the serious complications of influenza and benefit from vaccination. All individuals 65 years or older should be immunized with this vaccine.

Integrity signals

Registry

Crossref · 10.1001/archinte.158.16.1769

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
State- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1996 and 1997.
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Sternberg, T. V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 995
The Efficacy of Influenza Vaccination in Elderly Individuals
Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 883
SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS
GLEZEN, W. P. (1982) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036250 · Cited by 449
Influenza Vaccination Programs for Elderly Persons: Cost-Effectiveness in a Health Maintenance Organization
Mullooly, J. P., Bennett, M. D., Hornbrook, M. C., Barker, W. H., Williams, W. W., Patriarca, P. A., & Rhodes, P. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00008 · Cited by 330
Current Procedural Terminology
Leong, F. T. L. (2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n176 · Cited by 326
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.
Lui, K., & Kendal, A. P. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.6.712 · Cited by 319
Immunization Policies and Vaccine Coverage Among Adults
Williams, W. W., HICKSON, M. A., KANE, M. A., Kendal, A. P., SPIKA, J. S., & HINMAN, A. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-616 · Cited by 300

Flagged first, then by citations

Show all 41 references

Sorted by citations

Items 101–200 of 480

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy
Rothberg, M. B., Bellantonio, S., & Rose, D. N. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00007 · Cited by 90
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
Baxter, R. P., Ray, G. T., & FIREMAN, B. H. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.088 · Cited by 86
Identification of Influenza Endonuclease Inhibitors Using a Novel Fluorescence Polarization Assay
Baughman, B. M., Slavish, P. J., DuBois, R. M., Boyd, V. A., White, S. W., & Webb, T. R. (2012) · ACS Chemical Biology · doi:10.1021/cb200439z · Cited by 85
Predictors of Influenza Virus Vaccination Status in Hospitalized Children
Poehling, K. A., Speroff, T., Dittus, R. S., Griffin, M. R., Hickson, G. B., & Edwards, K. M. (2001) · PEDIATRICS · doi:10.1542/peds.108.6.e99 · Cited by 85
Inactivated Influenza Virus Vaccines in Children
Ruben, F. L. (2004) · Clinical Infectious Diseases · doi:10.1086/382883 · Cited by 84
Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease
de Diego‐Cabanes, C., Vila-Córcoles, Á., Ochoa, O., Rodríguez-Blanco, T., Salsench, E., Bejarano‐Romero, F., Muniain, M. D. P., Fortin, M., Canals, M., & EPIVAC Study Group (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn498 · Cited by 81
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine
Kopecky-Bromberg, S. A., Fraser, K. A., Pica, N., Carnero, E., Moran, T. M., Franck, R. W., Tsuji, M., & Palese, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.090 · Cited by 81
Safety and immunogenicity of influenza vaccination in individuals infected with HIV
Zanetti, A. R., Amendola, A., Besana, S., Boschini, A., & Tanzi, E. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00511-x · Cited by 81
Immunomodulating effect of influenza vaccination in the elderly differing in health status
Myśliwska, J. M., Trzonkowski, P., Szmit, E., Brydak, L. B., Machała, M. K., & Myśliwski, A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.005 · Cited by 79
Effect of Influenza on Functional Decline
Gozalo, P. L., Pop-Vicas, A. E., Feng, Z., Gravenstein, S., & Mor, V. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04048.x · Cited by 81
The Impact of Influenza-associated Respiratory Illnesses on Hospitalizations, Physician Visits, Emergency Room Visits, and Mortality
Menec, V. H., Black, C., MacWilliam, L., & Aoki, F. Y. (2003) · Canadian Journal of Public Health · doi:10.1007/bf03405054 · Cited by 78
National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland
Murphy, N. F., Simpson, C. R., McAlister, F. A., Stewart, S., Macintyre, K., Kirkpatrick, M., Chalmers, J., Redpath, A., Capewell, S., & McMurray, J. J. V. (2004) · Heart · doi:10.1136/hrt.2003.029553 · Cited by 78
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 76
Influenza Vaccination in the Elderly
Nichol, K. L. (2005) · Drugs & Aging · doi:10.2165/00002512-200522060-00004 · Cited by 75
Adult pneumococcal vaccination: a review of physician and patient barriers
Mieczkowski, T. A., & Wilson, S. A. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00463-7 · Cited by 74
Influenza: vaccination and treatment
Stephenson, I., & Nicholson, K. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00084301 · Cited by 74
The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 Years
Nichol, K. L., & Goodman, M. J. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916001-00009 · Cited by 74
Infections in Residents of Long‐Term Care Facilities: An Agenda for Research. Report of an Expert Panel
Richards, C. L. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50128.x · Cited by 73
Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re
Song, X., Chen, J., Sakwiwatkul, K., Li, R., & Hu, S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.009 · Cited by 72
Vaccination of patients with autoimmune inflammatory rheumatic diseases
Westra, J., Rondaan, C., van Assen, S., & Bijl, M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.206 · Cited by 72
Use of siRNAs to prevent and treat influenza virus infection
Ge, Q., Eisen, H. N., & Chen, J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.01.013 · Cited by 72
Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel
Johns, M. C., Eick, A. A., Blazes, D. L., Lee, S., Perdue, C. L., LIPNICK, R. J., Vest, K. G., Russell, K. L., DeFraites, R. F., & Sánchez, J. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010722 · Cited by 71
Current research on respiratory viral infections: Fourth International Symposium
Ison, M. G., Mills, J., Openshaw, P., Zambon, M. C. F. A., Osterhaus, A. D. M. E., & Hayden, F. G. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00055-4 · Cited by 70
The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age
Turner, D. A., Wailoo, A., Cooper, N. J., Sutton, A. J., Abrams, K. R., & Nicholson, K. G. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.12.033 · Cited by 68
From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis
Lee, L. W., Keller, S. C., Wilck, M. B., Gluckman, S. J., & Voorhees, A. S. V. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.046 · Cited by 68
Clinical effectiveness of conventional influenza vaccination in asthmatic children
SMITS, A. J., Hak, E., Stalman, W. A. B., van Essen, G. A., Hoes, A. W., & VERHEIJ, T. J. M. (2002) · Epidemiology and Infection · doi:10.1017/s0950268801006574 · Cited by 68
Influenza vaccine for patients with chronic obstructive pulmonary disease
Poole, P., Chacko, E., Wood-Baker, R., & Cates, C. J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002733 · Cited by 68
Reduced Hospitalizations and Death Associated With Influenza Vaccination Among Patients With and Without Diabetes
Heymann, A. D., Shapiro, Y., Chodick, G., Shalev, V., Kokia, E. S., Kramer, E., & Shemer, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2581 · Cited by 66
PA subunit of RNA polymerase as a promising target for anti-influenza virus agents
Nakazawa, M., Kadowaki, S.-E., Watanabe, I., Kadowaki, Y., Takei, M., & Fukuda, H. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.12.010 · Cited by 66
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study
Gorse, G. J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00748-x · Cited by 66
Influenza Vaccination among Minority Populations in the United States
Marin, M. G., JOHANSON, W. G., & Salas‐Lopez, D. (2002) · Preventive Medicine · doi:10.1006/pmed.2001.0983 · Cited by 65
Comparison of Immunogenicity and Safety of a Virosome Influenza Vaccine with Those of a Subunit Influenza Vaccine in Pediatric Patients with Cystic Fibrosis
Schaad, U. B., Bühlmann, U., Burger, R., Rüdeberg, A., Wilder‐Smith, A., Rutishauser, M., Sennhauser, F. H., Herzog, C., Zellmeyer, M., & Glück, R. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1163-1167.2000 · Cited by 64
Vaccine effectiveness in older individuals: What has been learned from the influenza-vaccine experience
Lang, P. O., Govind, S., Mitchell, W. A., Siegrist, C., & Aspinall, R. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.09.005 · Cited by 63
Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment
Bijl, M., Agmon‐Levin, N., Dayer, J.-M., Israeli, E., Gatto, M., & Shoenfeld, Y. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.015 · Cited by 62
S3-guideline on Ambulant Acquired Pneumonia and Deep Airway Infections
Höffken, G., Lorenz, J., Kern, W., Welte, T., Bauer, T. T., Dalhoff, K., Dietrich, E. S., Ewig, S., Gastmeier, P., Grabein, B., et al. (2005) · Pneumologie · doi:10.1055/s-2005-870988 · Cited by 60
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
Bruijn, I. D., Meyer, I., Gerez, L., Nauta, J. J. P., Giezeman‐Smits, K. M., & Palache, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.051 · Cited by 62
Hospital-Based Influenza and Pneumococcal Vaccination: Sutton's Law Applied to Prevention
Fedson, D. S., Houck, P. M., & Bratzler, D. W. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501716 · Cited by 62
Influenza Vaccination in 29 Countries
Ambrosch, F., & Fedson, D. S. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916001-00007 · Cited by 62
Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin-2 from the NS Gene Segment
Kittel, C., Ferko, B., Kurz, M., Grillari‐Voglauer, R., Sereinig, S., Romanova, J. R., Stiegler, G. M., Katinger, H. W. D., & Egorov, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10672-10677.2005 · Cited by 60
Probiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial
Wang, B., Hylwka, T., Smieja, M., Surrette, M., Bowdish, D. M. E., & Loeb, M. B. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15396 · Cited by 58
Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection
CHRISTENSON, B., & Lundbergh, P. (2002) · Epidemiology and Infection · doi:10.1017/s095026880200780x · Cited by 59
Addressing the burden of diabetes in the 21st century: better care and primary prevention.
Engelgau, M., Narayan, K. M. V., Saaddine, J., & Vinicor, F. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070143.71933.b0 · Cited by 70
Influenza Vaccination, Hospitalizations, and Costs Among Members of a Medicare Managed Care Plan
Davis, J. W., Lee, E., Taira, D. A., & Chung, R. S. (2001) · Medical Care · doi:10.1097/00005650-200112000-00003 · Cited by 58
Access to Preventive Services for Adults of Mexican Origin
Wallace, S. P., Gutiérrez, V. F., & Castañeda, X. (2007) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-007-9093-3 · Cited by 57
Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents
Ben‐Yehuda, A., Joseph, A., Barenholz, Y., Zeira, E., Even‐Chen, S., Louria‐Hayon, I., Babai, I., Zakay‐Rones, Z., Greenbaum, E., Galprin, I., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00251-2 · Cited by 57
Pharmacological Treatment in Patients with Heart Failure: Patients Knowledge and Occurrence of Polypharmacy, Alternative Medicine and Immunizations
Martínez‐Sellés, M., Robles, J. A. G., Muñoz, R., Serrano, J. A., Frades, E., Muñoa, M. D., & Almendral, J. M. (2003) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.09.009 · Cited by 56
Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years
Nichol, K. L., & Goodman, M. J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00124-x · Cited by 56
Is influenza vaccination cost effective for healthy people between ages 65 and 74 years?
Allsup, S. J., Haycox, A. R., Regan, M., & Gosney, M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.008 · Cited by 64
Influenza in Older Adults
Talbot, H. K. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.005 · Cited by 54
Preventive Strategies for Aspiration Pneumonia in Elderly Disabled Persons
Ohrui, T. (2005) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.207.3 · Cited by 55
Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents
Menec, V. H., MacWilliam, L., & Aoki, F. Y. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.10.m629 · Cited by 53
Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly
Pregliasco, F. E., Mensi, C., Serpilli, W., Speccher, L., Masella, P., & Belloni, A. (2001) · Aging Clinical and Experimental Research · doi:10.1007/bf03351492 · Cited by 53
Clinical experience with inactivated, virosomal influenza vaccine
de Bruijn, I. A., Nauta, J. J. P., Cramer, W., Gerez, L., & Palache, A. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.020 · Cited by 53
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF
Ehteshami‐Afshar, S., Mooney, L., Dewan, P., Desai, A. S., Lang, N. N., Lefkowitz, M. P., Petrie, M. C., Rizkala, A. R., Rouleau, J. L., Solomon, S. D., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019238 · Cited by 52
Vaccination of adults with asthma and COPD
Pesek, R., & Lockey, R. F. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02462.x · Cited by 52
Racial/ethnic differences in influenza vaccination in the Veterans Affairs Healthcare System.
Straits-tröster, K., Kahwati, L., Kinsinger, L., Orelien, J., Burdick, M. B., & Yevich, S. J. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.07.018 · Cited by 55
Mechanistic links between acute respiratory tract infections and acute coronary syndromes
Bazaz, R., Marriott, H. M., Francis, S., & Dockrell, D. H. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.009 · Cited by 52
Inactivated influenza vaccines
Bridges, C. B., Katz, J. M., Levandowski, R. A., & Cox, N. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50019-2 · Cited by 49
Influenza Vaccines Generated by Reverse Genetics
Subbarao, K., & Katz, J. M. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06099-5_9 · Cited by 49
The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae
Alymova, I. V., Portner, A., Takimoto, T., Boyd, K. L., Babu, Y. S., & McCullers, J. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.398-405.2005 · Cited by 49
After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly
Darvishian, M., Gefenaitė, G., Turner, R., Pechlivanoglou, P., van der Hoek, W., van den Heuvel, E. R., & Hak, E. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.02.009 · Cited by 47
Impact of a Winter Respiratory Virus Season on Patients With COPD and Association With Influenza Vaccination
Gorse, G. J., O’Connor, T., Young, S. L., Habib, M. P., Wittes, J. T., Neuzil, K. M., & Nichol, K. L. (2006) · CHEST Journal · doi:10.1378/chest.130.4.1109 · Cited by 47
Increasing influenza vaccination coverage in recommended population groups in Europe
Blank, P. R., & Szucs, T. D. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.7 · Cited by 46
Vaccine efficacy and T helper cell differentiation change with aging
Lefebvre, J. S., Lorenzo, E. C., Masters, A. R., Hopkins, J. W., Eaton, S. M., Smiley, S. T., & Haynes, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9254 · Cited by 46
Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program
Jansen, A. G. S. C., Sanders, E. A. M., Nichol, K. L., van Loon, A. M., Hoes, A. W., & Hak, E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.003 · Cited by 46
Bacterial Community-Acquired Pneumonia in Older Patients
Donowitz, G. R., & Cox, H. L. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.006 · Cited by 46
Influenza hemagglutinin vaccine with poly(γ-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity
Okamoto, S., Yoshii, H., Akagi, T., Akashi, M., Ishikawa, T., Okuno, Y., Takahashi, M., Yamanishi, K., & Mori, Y. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.051 · Cited by 46
How Far to the Hospital? The Effect of Hospital Closures on Access to Care
Buchmueller, T. C., Jacobson, M., & Wold, C. M. (2004) · National Bureau of Economic Research · doi:10.3386/w10700 · Cited by 46
Complications of influenza and benefits of vaccination
Nichol, K. L. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00105-x · Cited by 45
Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure
Fountoulaki, K., Tsiodras, S., Polyzogopoulou, E., Olympios, C. D., & Parissis, J. (2018) · Cardiology · doi:10.1159/000493572 · Cited by 46
Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME‐VAC) in young adults
Ben‐Yehuda, A., Joseph, A., Zeira, E., Even‐Chen, S., Louria‐Hayon, I., Babai, I., Zakay‐Rones, Z., Greenbaum, E., Barenholz, Y., & Kedar, E. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10345 · Cited by 44
Fatores associados à vacinação contra a influenza em idosos
Francisco, P. M. S. B., Donalísio, M. R., Barros, M. B. D. A., César, C. L. G., Carandina, L., & Goldbaum, M. (2006) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892006000400006 · Cited by 43
Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes
Zheng, B. Q., Zhang, Y., He, H., Marinova, E., Switzer, K. C., Wansley, D. L., Mbawuike, I. N., & Han, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6153 · Cited by 42
Influenza and Pneumococcal Vaccine Coverages in Geriatric Health Care Settings in France
Gavazzi, G., de Wazières, B., Lejeune, B., & Rothan‐Tondeur, M. (2007) · Gerontology · doi:10.1159/000105166 · Cited by 41
Immunizations in Older Adults
High, K. P. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.007 · Cited by 40
Importance of Employee Vaccination against Influenza in Preventing Cases in Long-Term Care Facilities
Wendelboe, A. M., Avery, C., de Andrade, B. B., Baumbach, J., & Landen, M. G. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/661916 · Cited by 40
Prophylactic vaccinations in chronic obstructive pulmonary disease: current status
Varkey, J. B., Varkey, A. B., & Varkey, B. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283218356 · Cited by 40
Effectiveness of influenza vaccination in the elderly in a community in Italy
Crocetti, E., Arniani, S., Bordoni, F., Maciocco, G., Zappa, M., & Buiatti, E. (2001) · European Journal of Epidemiology · doi:10.1023/a:1017978420601 · Cited by 40
Cost–benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria
Gasparini, R., Lucioni, C., Lai, P. L., Maggioni, P., Sticchi, L., Durando, P., Morelli, P., Comino, I., Calderisi, S., & Crovari, P. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00507-8 · Cited by 40
Pharmacoeconomics of Influenza Vaccination in the Elderly
Postma, M. J., Baltussen, R. M. P. M., Heijnen, M. A., van den Berg, L. T. W. D. J., & Jager, J. C. (2000) · Drugs & Aging · doi:10.2165/00002512-200017030-00005 · Cited by 40
Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years
Rodríguez-Blanco, T., Vila-Córcoles, Á., de Diego‐Cabanes, C., Gondar, O. O., Valdivieso, E., Armant, F. B., Morro, A., Herńndez, N., Martín, A., Calamote, F., et al. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18548 · Cited by 39
Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection
Okamoto, S., Kawabata, S., Fujitaka, H., Uehira, T., Okuno, Y., & Hamada, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.024 · Cited by 39
Preventing influenza: An overview of systematic reviews
van der Wouden, J. C., Bueving, H. J., & Poole, P. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.07.001 · Cited by 38
Influenza and atherosclerosis: vaccination for cardiovascular disease prevention
Madjid, M., Awan, I., Ali, M., Frazier, L. Q., & Casscells, W. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.91 · Cited by 38
Characteristics and outcome of viral pneumonia caused by influenza and Middle East respiratory syndrome-coronavirus infections: A 4-year experience from a tertiary care center
Idrees, M., Al-Baadani, A., Elzein, F. E., Alhemyadi, S. A., Khan, O., & Albenmousa, A. (2019) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_179_18 · Cited by 37
Influenza vaccination in the elderly: why are the overall benefits still hotly debated?
Trucchi, C., Paganino, C., Orsi, A., De Florentis, D., & Ansaldi, F. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2015.56.1.474 · Cited by 36
Influenza Vaccination in Adolescents With High-Risk Conditions
Nakamura, M., & Lee, G. M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3032 · Cited by 36
Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity
CHRISTENSON, B., Pauksen, K., & Sylvan, S. (2008) · Virology Journal · doi:10.1186/1743-422x-5-52 · Cited by 36
Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach
Feoli‐Fonseca, J. C., Oligny, L. L., Brochu, P., Simard, P., Falconi, S., & Yotov, W. V. (2001) · Journal of Medical Virology · doi:10.1002/1096-9071(200104)63:4 · Cited by 46
Influenza: Prospects for Control
Couch, R. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00015 · Cited by 36
Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts
Ferko, B., Kittel, C., Romanova, J. R., Sereinig, S., Katinger, H. W. D., & Egorov, A. (2006) · Journal of Virology · doi:10.1128/jvi.01645-06 · Cited by 35
Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease.
Madjid, M., Alfred, A., Sahai, A., Conyers, J. L., & Casscells, S. W. (2009) · PubMed · Cited by 36
Caregiver Psychological Distress as a Barrier to Influenza Vaccination Among Community-Dwelling Elderly With Dementia
Thorpe, J. M., Sleath, B., Thorpe, C. T. K., Houtven, C. V., Blalock, S. J., Landerman, L., Campbell, W. H., & Clipp, E. (2006) · Medical Care · doi:10.1097/01.mlr.0000215905.36968.76 · Cited by 39
Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study
Blumentals, W. A., & Schulman, K. L. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x242520 · Cited by 34
Promoting influenza vaccination of elderly patients in primary care
Humair, J. (2002) · Family Practice · doi:10.1093/fampra/19.4.383 · Cited by 34
Characteristics of Long-Term–Care Facility Residents Associated With Receipt of Influenza and Pneumococcal Vaccinations
Bardenheier, B. H., Shefer, A. M., McKibben, L., Roberts, H., & Bratzler, D. W. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502325 · Cited by 34
Influenza Vaccine Effectiveness in the Elderly Based on Administrative Databases: Change in Immunization Habit as a Marker for Bias
Salway, T. J., Skowronski, D. M., Hiebert, B. M., Janjua, N. Z., Roos, L. L., Caeseele, P. G. V., LAW, B. J., & Serres, G. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022618 · Cited by 34
Nursing home-acquired pneumonia: an emergency department treatment algorithm
Muder, R. R., Aghababian, R. V., Loeb, M. B., Solot, J. A., & Higbee, M. D. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004376 · Cited by 33
A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis
Hak, E., Wei, F., Grobbee, D. E., & Nichol, K. L. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.01.019 · Cited by 33
Standing Orders in an Ambulatory Setting Increases Influenza Vaccine Usage in Older People
Goebel, L. J., Neitch, S. M., & Mufson, M. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53320.x · Cited by 32

Authors: Nichol, K. L., Wuorenma, J., & von Sternberg, T.
Affiliations: University of Minnesota (US)
Regions Hospital (US)
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 1998-09-14
Volume: 158
Issue: 16
Pages: 1769
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinte.158.16.1769
OpenAlex: W2056095352
Cited by: 484
References: 41
Citations by year: 2025: 3 · 2024: 1 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 14 · 2017: 15 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 9 · 2012: 16
FWCI: 15.05
Type: journal article
Language: en
Open access: closed
Locations: Archives of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Social Sciences › Health › Vaccine Coverage and Hesitancy
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: influenza vaccination, older adults, vaccine effectiveness, pneumonia hospitalization, respiratory hospitalization, congestive heart failure, all-cause mortality, risk stratification, cost reduction, vaccination coverage, health maintenance organizations, diabetes mellitus, kidney disease, dementia, rheumatic diseases
MeSH terms: Aged, Aged, 80 and over, Female, Humans, Influenza, Human, Influenza Vaccines, Male, Risk, Risk Factors, Seasons, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks